2/4/2008 Targeting Astrocytes Slows Disease Progression in ALS In what the researchers say could be promising news in the quest to find a therapy to slow
the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, scientists at the University of California, San Diego (UCSD) School of Medicin... More...
A bacterial by - product known to be important in maintaining gut health may slow
the progression of amyotrophic lateral sclerosis, or ALS — a progressive, neurodegenerative disease.
Not exact matches
New research into
Amyotrophic Lateral Sclerosis (ALS)-- also known as motor neuron disease — shows that specific immune cells may help slow
progression of the disease, an important step towards developing new therapies to treat patients.
The prostaglandin E2 EP2 receptor accelerates disease
progression and inflammation in a model
of amyotrophic lateral sclerosis.